Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 343268, 8 pages
http://dx.doi.org/10.1155/2013/343268
Clinical Study

Plasma Granzyme B in ST Elevation Myocardial Infarction versus Non-ST Elevation Acute Coronary Syndrome: Comparisons with IL-18 and Fractalkine

1Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo 11566, Egypt
2Cardiology Department, Faculty of Medicine, Ain Shams University, Abassia, Cairo 11566, Egypt

Received 18 July 2013; Accepted 12 September 2013

Academic Editor: Peter Plomgaard

Copyright © 2013 Hala O. El-Mesallamy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. G. Members, V. L. Roger, A. S. Go et al., “Heart disease and stroke statistics—2012 update,” Circulation, vol. 125, pp. e2–e220, 2012. View at Publisher · View at Google Scholar
  2. P. K. Shah, “Inflammation and plaque vulnerability,” Cardiovascular Drugs and Therapy, vol. 23, no. 1, pp. 31–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. C. E. Brokopp, R. Schoenauer, P. Richards et al., “Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata,” European Heart Journal, vol. 32, no. 21, pp. 2713–2722, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. H. Clarke, N. Figg, J. J. Maguire et al., “Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis,” Nature Medicine, vol. 12, no. 9, pp. 1075–1080, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Schaub, T. Reichlin, C. Meune et al., “Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction,” Clinical Chemistry, vol. 58, no. 1, pp. 246–256, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Koenig and N. Khuseyinova, “Biomarkers of atherosclerotic plaque instability and rupture,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 15–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Adrain, B. M. Murphy, and S. J. Martin, “Molecular ordering of the caspase activation cascade initiated by the cytotoxic T lymphocyte/natural killer (CTL/NK) protease granzyme B,” The Journal of Biological Chemistry, vol. 280, no. 6, pp. 4663–4673, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. Buzza, L. Zamurs, J. Sun et al., “Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin,” The Journal of Biological Chemistry, vol. 280, no. 25, pp. 23549–23558, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. W. A. Boivin, D. M. Cooper, P. R. Hiebert, and D. J. Granville, “Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma,” Laboratory Investigation, vol. 89, no. 11, pp. 1195–1220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. R. S. Packard and P. Libby, “Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction,” Clinical Chemistry, vol. 54, no. 1, pp. 24–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Hulthe, W. McPheat, A. Samnegård, P. Tornvall, A. Hamsten, and P. Eriksson, “Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6,” Atherosclerosis, vol. 188, no. 2, pp. 450–454, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. de Nooijer, J. H. von der Thüsen, C. J. N. Verkleij et al., “Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 12, pp. 2313–2319, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Hartford, O. Wiklund, L. M. Hultén et al., “Interleukin-18 as a predictor of future events in patients with acute coronary syndromes,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 10, pp. 2039–2046, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Zernecke, E. Shagdarsuren, and C. Weber, “Chemokines in atherosclerosis an update,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 11, pp. 1897–1908, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Umehara, E. T. Bloom, T. Okazaki, Y. Nagano, O. Yoshie, and T. Imai, “Fractalkine in vascular biology: from basic research to clinical disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 1, pp. 34–40, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Li, Y. Guo, X. Luan et al., “Independent roles of monocyte chemoattractant protein-1, regulated on activation, normal T-cell expressed and secreted and fractalkine in the vulnerability of coronary atherosclerotic plaques,” Circulation Journal, vol. 76, no. 9, pp. 2167–2173, 2012. View at Publisher · View at Google Scholar
  17. The Joint European Society of Cardiology/American College of Cardiology Committee, “Myocardial infarction redefined—a consensus document of the joint european society of cardiology/American college of cardiology committee for the redefinition of myocardial infarction,” European Heart Journal, vol. 21, no. 18, pp. 1502–1513, 2000. View at Publisher · View at Google Scholar
  18. E. J. Wasserman and N. M. Shipley, “Atherothrombosis in acute coronary syndromes: mechanisms, markers, and mediators of vulnerability,” Mount Sinai Journal of Medicine, vol. 73, no. 1, pp. 431–439, 2006. View at Google Scholar · View at Scopus
  19. J. M. Heo, J. H. Park, J. H. Kim et al., “Comparison of inflammatory markers between diabetic and nondiabetic ST segment elevation myocardial infarction,” Journal of Cardiology, vol. 60, no. 3, pp. 204–209, 2012. View at Publisher · View at Google Scholar
  20. C. G. Gustavsson and C. Agardh, “Inflammatory activity increases with haemoglobin A1c in patients with acute coronary syndrome,” Scandinavian Cardiovascular Journal, vol. 43, no. 6, pp. 380–385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Ikemoto, Y. Hojo, H. Kondo et al., “Plasma granzyme B as a predicting factor of coronary artery disease—clinical significance in patients with chronic renal failure,” Journal of Cardiology, vol. 54, no. 3, pp. 409–415, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Kondo, Y. Hojo, R. Tsuru et al., “Elevation of plasma granzyme B levels after acute myocardial infarction: correlation with left ventricular remodeling,” Circulation Journal, vol. 73, no. 3, pp. 503–507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Skjelland, A. E. Michelsen, K. Krohg-Sørensen et al., “Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity,” Atherosclerosis, vol. 195, no. 2, pp. e142–e146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Saito, H. Kondo, and Y. Hojo, “Granzyme B as a novel factor involved in cardiovascular diseases,” Journal of Cardiology, vol. 57, no. 2, pp. 141–147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. W. J. Kim, H. Kim, K. Suk, and W. H. Lee, “Macrophages express granzyme B in the lesion areas of atherosclerosis and rheumatoid arthritis,” Immunology Letters, vol. 111, no. 1, pp. 57–65, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. J. C. Choy, P. C. McDonald, A. C. Suarez et al., “Granzyme B in atherosclerosis and transplant vascular disease: association with cell death and atherosclerotic disease severity,” Modern Pathology, vol. 16, no. 5, pp. 460–470, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Hendel, D. Cooper, T. Abraham, H. Zhao, M. F. Allard, and D. J. Granville, “Proteinase inhibitor 9 is reduced in human atherosclerotic lesion development,” Cardiovascular Pathology, vol. 21, no. 1, pp. 28–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Tsuru, H. Kondo, Y. Hojo et al., “Increased granzyme B production from peripheral blood mononuclear cells in patients with acute coronary syndrome,” Heart, vol. 94, no. 3, pp. 305–310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. B. W. C. Wong, D. Wong, and B. M. McManus, “Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease,” Cardiovascular Pathology, vol. 11, no. 6, pp. 332–338, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. A. G. Ziakas, K. C. Koskinas, E. Souliou et al., “Serial measurements of acute phase proteins in patients with acute coronary syndrome,” Hellenic Journal of Cardiology, vol. 52, no. 4, pp. 293–298, 2011. View at Google Scholar · View at Scopus
  31. S. S. Habib, M. I. Kurdi, Z. Al Aseri, and M. O. Suriya, “CRP levels are higher in patients with ST elevation than non-ST elevation acute coronary syndrome,” Arquivos Brasileiros de Cardiologia, vol. 96, no. 1, pp. 13–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. C. Zhang, J. J. Wei, F. Wang, M. T. Chen, and M. Z. Zhang, “Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome,” Cell Biochemistry and Biophysics, vol. 62, no. 2, pp. 365–372, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. N. D. Brunetti, I. Munno, P. L. Pellegrino et al., “Inflammatory cytokines imbalance in the very early phase of acute coronary syndrome: correlations with angiographic findings and in-hospital events,” Inflammation, vol. 34, no. 1, pp. 58–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Ghanavatian, R. A. Stein, D. Atar, L. Hole, and S. Agewall, “The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction,” Clinical Laboratory, vol. 57, no. 9-10, pp. 771–776, 2011. View at Google Scholar · View at Scopus
  35. T. Kyaw, A. Winship, C. Tay et al., “Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice,” Circulation, vol. 127, no. 9, pp. 1028–1039, 2013. View at Publisher · View at Google Scholar
  36. M. Nishimura, H. Umehara, T. Nakayama et al., “Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by Cx3CR1 expression,” Journal of Immunology, vol. 168, no. 12, pp. 6173–6180, 2002. View at Google Scholar · View at Scopus
  37. I. S. Afonina, G. A. Tynan, S. E. Logue et al., “Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α,” Molecular Cell, vol. 44, no. 2, pp. 265–278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Omoto, K. Yamanaka, K. Tokime et al., “Granzyme B is a novel interleukin-18 converting enzyme,” Journal of Dermatological Science, vol. 59, no. 2, pp. 129–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Ludwig, T. Berkhout, K. Moores, P. Groot, and G. Chapman, “Fractalkine is expressed by smooth muscle cells in response to IFN-γ and TNF-α and is modulated by metalloproteinase activity,” Journal of Immunology, vol. 168, no. 2, pp. 604–612, 2002. View at Google Scholar · View at Scopus
  40. S. Apostolakis, E. Krambovitis, Z. Vlata, G. E. Kochiadakis, S. Baritaki, and D. A. Spandidos, “CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators,” Thrombosis Research, vol. 121, no. 3, pp. 387–395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. G. E. Garcia, Y. Xia, S. Chen et al., “NF-κB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1β, TNF-α, and LPS,” Journal of Leukocyte Biology, vol. 67, no. 4, pp. 577–584, 2000. View at Google Scholar · View at Scopus